Liping Ma1, Long Qian2, Zhibin Zeng1, Cuiyun Sheng1, Yang Wang1, Gen Li3, and Gaoyun Wu1
1Department of Radiology, Huazhong University of Science and Technology Union Shenzhen Hospital, Shenzhen, China, 2MR Research, GE Healthcare, Bejing, China, 3Department of Emergency, Huazhong University of Science and Technology Union Shenzhen Hospital, Shenzhen, China
Synopsis
Quantification of fat fraction (FF) and R2* in areas of bone
marrow edema (BME) and fat metaplasia in different stages Ankylosing Spondylitis (AS). 75 AS in 3 different stage (early acute group,
late acute group, stable group), 42 BME and 39 fat metaplasia were detected. Difference of FF, R2* in BME and fat metaplasia
in different stages were compared and relationship between FF and R2* were analyzed. Result showed R2* in
fat metaplasia,
but not in BME, is significantly negative with FF. FF
and R2* measurements can quantitatively analyze bone marrow component change in AS.
Introduction
Sacroiliac joint
inflammation-sacroiliitis is the final irreversible outcome of Ankylosing
Spondylitis (AS) with an insidious progression posing major quantitative evaluative challenges. As an autoimmune disease, the bone marrow component of trabecular bone, fat
changed gradually over the progression. Admittedly, both new bone formation and bone
destruction are key features of AS[1] . On the contrary, AS
patients are at great risk of fractures due to the presence of adipocytes and
bone loss, moreover, metaplasia is assumed to be a key intermediary step
between inflammation and formation of new bone[2]. Yet bone metabolic changes in AS remain unclear. Taking advantage of significant MR technical advances in reliable
quantification of marrow composition. Recent osteoporosis and fat‐water‐bone phantom modeling researches[3,
4] have focused on the relationship
between bone marrow density (BMD) and fat component, but not yet widely used in AS. Our aim is to evaluate the feasibility of quantification of FF, R2*as makers of
bone marrow composition changes in the AS in different stages and explore the correlation
between FF and R2*.Methods
75
AS patients (30 males and 45 females, with
mean age 31.1y) underwent IDEAl-IQ of the sacroiliac joints at 3T GE MRI. AS
patients were classified into acute group (AG) (25 males and 24 females, with mean age 30.4y) and
stable group (SG) (13
males and 14 females, with mean age 32.6y) according to Bath
ankylosing spondylitis disease activity index (BASDAI) score with C-reactive
protein (CRP). Of these acute cohort, the first diagnosed acute patients
without radiographic damage nor intervention therapy were defined as the early
acute group (EA) (9
males and 15 females, with mean age 30.0y), while others as
the late acute group (LA) (9 males and 15 females, with mean age 32.6y). Patients without BME, fat metaplasia
nor lack of BASDAI
scores, CRP were excluded. Finally, 42 patients with bone marrow edema (BME) (16 from
EA, 17 from LA, 9 from SG) and 39 patients with fat metaplasia (9 from EA, 17
from LA, 13 from SG) were included. Difference of FF, R2* in BME and
fat metaplasia among groups were compared and relationship between FF and R2*
were analyzed. Data statistics were analyzed using Kruskal-Wallis
test and Spearman correlation test.Results
Only
FF in BME was significantly different among patient groups (p=0.001), with median (interquartile range (IQR)) FF values
were 17.05% (10.82%–27.35%), 27.93% (23.50%–43.03%), 52.05% (50.12%–62.29%) in
EA, LA and SG respectively. In fat metaplasia, there was no significantly
different parameter among patient groups, with median FF value of overall fat metaplasia
was 85.44% (77.30%–91.20%), FF of fat metaplasia significant negative
correlation with R2*(p=0.00, r=-0.488).Discussion
BME always treated as hallmark of acute
stage[1],
but we detected subchondral mild hyperintensity lesion on T2WI sequences with
FS as uncomplete resolved edema in SG, the reason for that was we classified
groups totally according to BASDAI and CRP. FF of BME in EA was significantly
lower than that in LA and SG. Previous study[5]
investigated
quantification of FF in in normal bone marrow, bone marrow edema, and fat
metaplasia in AS and suggested FF can help to determine
radiologic progression. In
our study of FF in BME in different active inflammation stages showed the
proportion of fat deposition was increased as the BME resolution progressed. It supported the hypothesis that fat
metaplasia is usually assumed to be an inherent characteristic of the tissue
response following resolution of inflammation[1].
For fat metaplasia, we also detected fat metaplasia either in the adjacent subchondral bone
marrow or around edema or erosion in EA, though fat metaplasia was treated as established feature of AS in the later
period. But there was no significant deference in FF of fat metaplasia
among groups, however, we observed more extensive fat metaplasia in patients at
late acute stage and stable stage.
FF in fat metaplasia was negative related
to R2*. Fat metaplasia is presumably an intermediate stage between active
inflammation and new bone formation[6].
Recently new immunological discoveries revealed adipocytes as a secretory and
metabolically active organ contributing to bone metabolism[7]. Fat metaplasia
correspond to presence of adipocytes, resulting to change of cellular
homeostasis towards diminution of osteoclasts in the bone marrow of patients
with AS, because marrow adipocytes and osteoblasts originate from the same bone
marrow mesenchymal stromal cell which terminally differentiated to different
cells.
Previous
osteoporosis studies[8, 9] suggest that the
relationship between BMD and R2* is approximately linear. And Bray et al[4] investigated the
BMD and R2* in a phantom containing different proportion of fat, water, and
trabecular bone, and found a positive correlation between BMD and R2*. Since bony
trabeculae are more diamagnetic than the surrounding marrow make the rate of
signal decay R2* increased. Bray[4] found R2* was significantly reduced in areas of fat metaplasia
in AS patient. In our study, we found only FF in fat metaplasia, but not
FF in BME, was significant related to R2*, indicating that R2* was also
influenced by other bone marrow composition. The influencing factors need to be
further studied.Conclusion
FF and R2* measurements can quantitatively analyze bone marrow component change in AS. Acknowledgements
The author would like to thank the staff of department of Radiology, Department of Rheumatology and Department of Pain in Shenzhen Hospital of Huazhong University of Science and Technology for their help in case screening and data collection.Thanks to Dr. Qian for his technical support in data analysis and measurement.
This work was supported by the Shenzhen Nanshan District Science and Technology Project (NS129).
References
[1] MAKSYMOWYCH W P, LAMBERT R G, OSTERGAARD M, et al. MRI lesions in
the sacroiliac joints of patients with spondyloarthritis: an update of
definitions and validation by the ASAS MRI working group [J]. Ann Rheum Dis,
2019, 78(11): 1550-1558.
[2] MAKSYMOWYCH W P, WICHUK S, CHIOWCHANWISAWAKIT P, et al. Fat
metaplasia on MRI of the sacroiliac joints increases the propensity for disease
progression in the spine of patients with spondyloarthritis [J]. RMD Open,
2017, 3(1): e000399.
[3] LEONHARDT Y, GASSERT F T, FEUERRIEGEL G, et al. Vertebral bone
marrow T2* mapping using chemical shift encoding-based water-fat separation in
the quantitative analysis of lumbar osteoporosis and osteoporotic fractures
[J]. Quant Imaging Med Surg, 2021, 11(8): 3715-25.
[4] BRAY T J P, BAINBRIDGE A, PUNWANI S, et al. Simultaneous
Quantification of Bone Edema/Adiposity and Structure in Inflamed Bone Using
Chemical Shift-Encoded MRI in Spondyloarthritis [J]. Magn Reson Med, 2018,
79(2): 1031-1042.
[5] KOO B S, SONG Y, SHIN J H, et al. Evaluation of disease chronicity
by bone marrow fat fraction using sacroiliac joint magnetic resonance imaging
in patients with spondyloarthritis: A retrospective study [J]. Int J Rheum Dis,
2019, 22(4): 734-741.
[6] MAKSYMOWYCH W P, WICHUK S, CHIOWCHANWISAWAKIT P, et al. Fat
metaplasia and backfill are key intermediaries in the development of sacroiliac
joint ankylosis in patients with ankylosing spondylitis [J]. Arthritis
Rheumatol, 2014, 66(11): 2958-2967.
[7] TENCEROVA M, FERENCAKOVA M, KASSEM M. Bone marrow adipose tissue:
Role in bone remodeling and energy metabolism [J]. Best Pract Res Clin
Endocrinol Metab, 2021, 35(4): 101545.
[8] MACEWAN I J, GLEMBOTSKI N E, D'LIMA D, et al. Proton density water
fraction as a biomarker of bone marrow cellularity: validation in ex vivo spine
specimens [J]. Magn Reson Imaging, 2014, 32(9): 1097-1101.
[9] KWACK K S, LEE H D, JEON S W, et al. Comparison of proton density
fat fraction, simultaneous R2*, and apparent diffusion coefficient for
assessment of focal vertebral bone marrow lesions [J]. Clin Radiol, 2020,
75(2): 123-130.